Heyman Richard A.
11 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-06 | ORIC | Oric Pharmaceuticals, Inc. | Sale | 300 | $12.00 | $3,600.00 | filing |
| 2026-02-17 | ELVN | Enliven Therapeutics, Inc. | Sale | 1,230 | $26.18 | $32,196.36 | filing |
| 2026-01-20 | ELVN | Enliven Therapeutics, Inc. | Sale | 718 | $26.96 | $19,354.41 | filing |
| 2026-01-20 | ELVN | Enliven Therapeutics, Inc. | Sale | 512 | $26.46 | $13,547.11 | filing |
| 2026-01-16 | ORIC | Oric Pharmaceuticals, Inc. | Sale | 3,500 | $12.00 | $42,016.10 | filing |
| 2026-01-16 | ORIC | Oric Pharmaceuticals, Inc. | Sale | 3,200 | $12.00 | $38,414.72 | filing |
| 2026-01-09 | ELVN | Enliven Therapeutics, Inc. | Sale | 4,285 | $25.00 | $107,125.43 | filing |
| 2026-01-08 | ELVN | Enliven Therapeutics, Inc. | Sale | 8,015 | $25.04 | $200,655.53 | filing |
| 2026-01-08 | ELVN | Enliven Therapeutics, Inc. | Sale | 1,620 | $25.00 | $40,500.00 | filing |
| 2025-10-03 | ORIC | Oric Pharmaceuticals, Inc. | Option exercise | 31,353 | $1.60 | $50,164.80 | filing |
| 2025-10-03 | ORIC | Oric Pharmaceuticals, Inc. | Option exercise | 1,447 | $3.75 | $5,426.25 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.